Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015 (2015), Article ID 293896, 9 pages
http://dx.doi.org/10.1155/2015/293896
Research Article

New-Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients

1Department of Nephrology, Baskent University Medical School, 06490 Ankara, Turkey
2Department of Internal Medicine, Baskent University Medical School, 06490 Ankara, Turkey
3Department of Transplantation Surgery, Baskent University Medical School, 06490 Ankara, Turkey

Received 1 December 2014; Revised 17 February 2015; Accepted 24 February 2015

Academic Editor: Subrata Chakrabarti

Copyright © 2015 Siren Sezer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. L. Kasiske, J. J. Snyder, D. Gilbertson, and A. J. Matas, “Diabetes mellitus after kidney transplantation in the United States,” American Journal of Transplantation, vol. 3, no. 2, pp. 178–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. F. G. Cosio, Y. Kudva, M. van der Velde et al., “New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation,” Kidney International, vol. 67, no. 6, pp. 2415–2421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. F. Crutchlow and R. D. Bloom, “Transplant-associated hyperglycemia: a new look at an old problem,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 2, pp. 343–355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. F. G. Cosio, T. E. Pesavento, S. Kim, K. Osei, M. Henry, and R. M. Ferguson, “Patient survival after renal transplantation: IV. Impact of post-transplant diabetes,” Kidney International, vol. 62, no. 4, pp. 1440–1446, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Hjelmesæth, A. Hartmann, T. Leivestad et al., “The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events,” Kidney International, vol. 69, no. 3, pp. 588–595, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. C. R. Gross, C. Limwattananon, B. Matthees, J. L. Zehrer, and K. Savik, “Impact of transplantation on quality of life in patients with diabetes and renal dysfunction,” Transplantation, vol. 70, no. 12, pp. 1736–1746, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. V. M. Montori, A. Basu, P. J. Erwin, J. A. Velosa, S. E. Gabriel, and Y. C. Kudva, “Posttransplantation diabetes: a systematic review of the literature,” Diabetes Care, vol. 25, no. 3, pp. 583–592, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. F. G. Cosio, T. E. Pesavento, K. Osei, M. L. Henry, and R. M. Ferguson, “Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years,” Kidney International, vol. 59, no. 2, pp. 732–737, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Räkel and A. D. Karelis, “New-onset diabetes after transplantation: risk factors and clinical impact,” Diabetes & Metabolism, vol. 37, no. 1, pp. 1–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. O. Moratalla, C. F. Lanatta, Y. B. Morilla et al., “Left ventricular structure and function in long-term kidney transplantation: the influence of glucose metabolism and oxidative stress,” Transplantation Proceedings, vol. 40, no. 9, pp. 2912–2915, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Hernández, “Left ventricular hypertrophy after renal transplantation: new approach to a deadly disorder,” Nephrology Dialysis Transplantation, vol. 19, no. 7, pp. 1682–1686, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Hernández, A. González, M. Rufino et al., “Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass,” Nephrology Dialysis Transplantation, vol. 22, no. 9, pp. 2678–2685, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. R. C. Ferreira, V. A. Moisés, A. Tavares, and A. Pacheco-Silva, “Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile,” Transplantation, vol. 74, no. 11, pp. 1580–1587, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. N. A. Tomilina, G. I. Storozhakov, G. E. Gendlin et al., “Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney,” Terapevticheskii Arkhiv, vol. 79, no. 6, pp. 34–40, 2007. View at Google Scholar · View at Scopus
  15. A. Benetos, M. Safar, A. Rudnichi et al., “Pulse pressure: a predictor of long-term cardiovascular mortality in a french male population,” Hypertension, vol. 30, no. 6, pp. 1410–1415, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. A. Henry, P. J. Kostense, A. M. W. Spijkerman et al., “Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn study,” Circulation, vol. 107, no. 16, pp. 2089–2095, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. N. M. van Popele, D. E. Grobbee, M. L. Bots et al., “Association between arterial stiffness and atherosclerosis: the Rotterdam Study,” Stroke, vol. 32, no. 2, pp. 454–460, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Cruickshank, L. Riste, S. G. Anderson, J. S. Wright, G. Dunn, and R. G. Gosling, “Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?” Circulation, vol. 106, no. 16, pp. 2085–2090, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-M. Chung, Y.-S. Lin, C.-M. Chu et al., “Arterial stiffness is the independent factor of left ventricular hypertrophy determined by electrocardiogram,” American Journal of the Medical Sciences, vol. 344, no. 3, pp. 190–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. O. Ojo, “Cardiovascular complications after renal transplantation and their prevention,” Transplantation, vol. 82, no. 5, pp. 603–611, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Zoungas, P. G. Kerr, S. Chadban et al., “Arterial function after successful renal transplantation,” Kidney International, vol. 65, no. 5, pp. 1882–1889, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kato, M. Matsuhisa, N. Ichimaru et al., “The impact of new-onset diabetes on arterial stiffness after renal transplantation,” Endocrine Journal, vol. 55, no. 4, pp. 677–683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Wilkinson, J. Davidson, F. Dotta et al., “Guidelines for the treatment and management of new-onset diabetes after transplantation,” Clinical Transplantation, vol. 19, no. 3, pp. 291–298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Davidson, A. H. Wilkinson, J. Dantal et al., “New-onset diabetes after transplantation: 2003 international consensus guidelines,” Transplantation, vol. 7, pp. SS3–SS24, 2003. View at Google Scholar
  25. S. Baid, A. B. Cosimi, M. Lin Farrell et al., “Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal, relationship with hepatitis C virus allograft hepatitis, and impact on mortality,” Transplantation, vol. 72, no. 6, pp. 1066–1072, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Ye, H.-T. Kuo, M. S. Sampaio, Y. Jiang, and S. Bunnapradist, “Risk factors for development of new-onset diabetes mellitus after transplant in adult lung transplant recipients,” Clinical Transplantation, vol. 25, no. 6, pp. 885–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. P. Wauters, F. G. Cosio, M. L. S. Fernandez, Y. Kudva, P. Shah, and V. E. Torres, “Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation,” Transplantation, vol. 94, no. 4, pp. 377–382, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Pham, “New onset diabetes after transplantation (NODAT): an overview,” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. 4, pp. 175–186, 2011. View at Publisher · View at Google Scholar
  29. H. A. Chakkera, E. J. Weil, C. M. Swanson et al., “Pretransplant risk score for new-onset diabetes after kidney transplantation,” Diabetes Care, vol. 34, pp. 2141–2145, 2011. View at Publisher · View at Google Scholar
  30. E. Rodrigo, G. Fernández-Fresnedo, R. Valero et al., “New-onset diabetes after kidney transplantation: risk factors,” Journal of the American Society of Nephrology, vol. 17, no. 3, pp. S291–S295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. R. S. Woodward, M. A. Schnitzler, J. Baty et al., “Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients,” American Journal of Transplantation, vol. 3, no. 5, pp. 590–598, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. R. C. Andrews and B. R. Walker, “Glucocorticoids and insulin resistance: old hormones, new targets,” Clinical Science, vol. 96, no. 5, pp. 513–523, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. J. E. Henriksen, F. Alford, G. M. Ward, and H. Beck-Nielsen, “Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients,” Diabetologia, vol. 40, no. 12, pp. 1439–1448, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Kamar, O. Toupance, M. Buchler et al., “Evidence that clearance of hepatitis C virus RNA after α-interferon therapy in dialysis patients is sustained after renal transplantation,” Journal of the American Society of Nephrology, vol. 14, no. 8, pp. 2092–2098, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. G. V. R. Prasad, S. J. Kim, M. Huang et al., “Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins),” American Journal of Transplantation, vol. 4, no. 11, pp. 1897–1903, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Hjelmesaeth, T. Jenssen, M. Hagen, T. Egeland, and A. Hartmann, “Determinants of insulin secretion after renal transplantation,” Metabolism: Clinical and Experimental, vol. 52, no. 5, pp. 573–578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Boudina and E. D. Abel, “Diabetic cardiomyopathy revisited,” Circulation, vol. 115, no. 25, pp. 3213–3223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Galderisi, K. M. Anderson, P. W. F. Wilson, and D. Levy, “Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study),” American Journal of Cardiology, vol. 68, no. 1, pp. 85–89, 1991. View at Publisher · View at Google Scholar · View at Scopus
  39. R. B. Devereux, M. J. Roman, M. Paranicas et al., “Impact of diabetes on cardiac structure and function: the Strong Heart Study,” Circulation, vol. 101, no. 19, pp. 2271–2276, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. M. K. Rutter, H. Parise, E. J. Benjamin et al., “Impact of glucose intolerance and insulin resistance on cardiac structure and function. Sex-related differences in the Framingham Heart Study,” Circulation, vol. 107, no. 3, pp. 448–454, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. R. S. Velagaleti, P. Gona, M. L. Chuang et al., “Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study,” Circulation: Cardiovascular Imaging, vol. 3, no. 3, pp. 257–263, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Ilercil, R. B. Devereux, M. J. Roman et al., “Relationship of impaired glucose tolerance to left ventricular structure and function: the strong heart study,” American Heart Journal, vol. 141, no. 6, pp. 992–998, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. J. P. Boudreaux, L. McHugh, D. M. Canafax et al., “The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients,” Transplantation, vol. 44, no. 3, pp. 376–381, 1987. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Sharif and K. Baboolal, “Risk factors for new-onset diabetes after kidney transplantation,” Nature Reviews Nephrology, vol. 6, no. 7, pp. 415–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. The International Expert Committee, “International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes,” Diabetes Care, vol. 32, no. 7, pp. 1327–1334, 2009. View at Publisher · View at Google Scholar
  46. C. D. Saudek, W. H. Herman, D. B. Sacks, R. M. Bergenstal, D. Edelman, and M. B. Davidson, “A new look at screening and diagnosing diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 7, pp. 2447–2453, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Tatar, F. Kircelli, M. S. Demirci et al., “Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation,” International Urology and Nephrology, vol. 45, no. 1, pp. 251–258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. A. A. Ginde, E. Cagliero, D. M. Nathan, and C. A. Camargo Jr., “Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population,” Journal of General Internal Medicine, vol. 23, no. 9, pp. 1346–1353, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Taddei, R. Nami, R. M. Bruno, I. Quatrini, and R. Nuti, “Hypertension, left ventricular hypertrophy and chronic kidney disease,” Heart Failure Reviews, vol. 16, no. 6, pp. 615–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. R. N. Foley, P. S. Parfrey, J. D. Harnett et al., “Clinical and echocardiographic disease in patients starting end-stage renal disease therapy,” Kidney International, vol. 47, no. 1, pp. 186–192, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah, “NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure,” Cardiovascular Research, vol. 71, no. 2, pp. 208–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. D. R. McCance, D. G. Dyer, J. A. Dunn et al., “Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus,” The Journal of Clinical Investigation, vol. 91, no. 6, pp. 2470–2478, 1993. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. M. Li, M. Steffes, T. Donnelly et al., “Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 9, pp. 3902–3907, 1996. View at Publisher · View at Google Scholar · View at Scopus
  54. K.-C. Chang, C.-D. Tseng, T.-F. Chou et al., “Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes,” European Journal of Clinical Investigation, vol. 36, no. 1, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. J. M. Hayden and P. D. Reaven, “Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors,” Current Opinion in Lipidology, vol. 11, no. 5, pp. 519–528, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. P. J. Dunn, R. A. Cole, J. S. Soeldner, and R. E. Gleason, “Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance,” Annals of Internal Medicine, vol. 91, no. 3, pp. 390–396, 1979. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Mutinelli-Szymanski, A. Caille, F. Tranquart et al., “Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation,” Transplant International, vol. 25, no. 4, pp. 464–470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. T. W. Gress, F. J. Nieto, E. Shahar, M. R. Wofford, and F. L. Brancati, “Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus,” The New England Journal of Medicine, vol. 342, no. 13, pp. 905–912, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. M. E. Safar, “Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors,” Current Opinion in Nephrology & Hypertension, vol. 10, no. 2, pp. 257–261, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Olsson and P.-O. Carlsson, “The pancreatic islet endothelial cell: emerging roles in islet function and disease,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 4, pp. 492–497, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. L. W. Oberley, “Free radicals and diabetes,” Free Radical Biology and Medicine, vol. 5, no. 2, pp. 113–124, 1988. View at Publisher · View at Google Scholar · View at Scopus
  62. R. Asmar, A. Rudnichi, J. Blacher, G. M. London, and M. E. Safar, “Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations,” The American Journal of Hypertension, vol. 14, no. 2, pp. 91–97, 2001. View at Publisher · View at Google Scholar · View at Scopus